RARX

Ra Pharmaceuticals, Inc. Common Stock
RARX

Delisted

RARX was delisted on the 1st of April, 2020.

76 hedge funds and large institutions have $130M invested in Ra Pharmaceuticals, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 37 increasing their positions, 10 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
+10
Holders Change %
+15.15%
% of All Funds
1.74%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
21
Increased
37
Reduced
10
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
PC
76
Polar Capital
United Kingdom
-$1.06M -125,000 Closed
Point72 Asset Management
77
Point72 Asset Management
Connecticut
-$850K -100,000 Closed
Jacobs Levy Equity Management
78
Jacobs Levy Equity Management
New Jersey
-$397K -46,660 Closed
Russell Investments Group
79
Russell Investments Group
United Kingdom
-$363K -42,845 Closed
SIM
80
Spark Investment Management
New York
-$336K -39,600 Closed
EMG
81
Ellington Management Group
Connecticut
-$297K -34,900 Closed
MF
82
Magnetar Financial
Illinois
-$186K -21,844 Closed
Squarepoint
83
Squarepoint
New York
-$167K -19,592 Closed
PP
84
Paloma Partners
Connecticut
-$154K -18,172 Closed
Parallax Volatility Advisers
85
Parallax Volatility Advisers
California
-$15K -1,806 Closed
Macquarie Group
86
Macquarie Group
Australia
-$10K -1,200 Closed